Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex.
about
Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systemsTargeted in vitro and in vivo gene transfer into T lymphocytes: potential of direct inhibition of allo-immune activationNon-viral peptide-based approaches to gene delivery.Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma.Receptor-mediated targeting of gene delivery vectors: insights from molecular mechanisms for improved vehicle design.Extrachromosomal recombination occurs efficiently in cells defective in various DNA repair systemsRedirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens.Targeted adenovirus-mediated gene delivery to T cells via CD3.An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastomaDesign, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system.History of Polymeric Gene Delivery Systems.How to Tackle the Challenge of siRNA Delivery with Sequence-Defined Oligoamino Amides.DNA/polyethylenimine transfection particles: influence of ligands, polymer size, and PEGylation on internalization and gene expression.Receptor-mediated gene delivery to human peripheral blood mononuclear cells using anti-CD3 antibody coupled to polyethylenimine.The transfection of Jurkat T-leukemic cells by use of pH sensitive immunoliposomes.The transfection of Jurkat T-leukemic cells by use of pH-sensitive immunoliposomes.Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway.Targeted gene transfer for adenocarcinoma using a combination of tumor-specific antibody and tissue-specific promoter.Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.
P2860
Q28476268-D6FDBCE1-B390-490B-9B03-E41C3D9A29F6Q33263272-E4441C1B-4C46-4778-86DD-8FD2C48BDD6DQ33842955-F9934E46-F79E-442C-863A-6693B72CC13BQ33881828-10BF7803-2F65-4A18-9A78-75BC3583EA63Q34076933-172F4DBD-ED5F-4C20-A911-45AEA0C216E6Q34598022-51BB5E9B-D333-4D2A-9EC4-D884D9AA7A82Q35586270-4A2F447A-0A82-49DC-B8B3-AFEA8462FD98Q35895774-7BFFFBDB-5F94-4977-BB0B-02F69BC6B600Q36093931-B9750F2F-4D0A-4753-9778-103157AF5897Q38067265-AE463D40-4D55-4A0F-8C97-8DB26C812915Q38358020-8809B703-7BC1-41AE-9F96-A41C81BC803AQ38759514-0408711F-1726-4DF1-A00A-87714EFF3A49Q40689442-36179210-D793-4BE4-A5D9-E69090F2F06CQ42104292-54AC129F-1E08-4CE4-896A-95736BB55B1DQ43583256-7068F37E-8216-4750-B9D9-AADA178962F9Q44273058-04FD373B-D921-4D48-844C-FD765927E9FEQ44326718-25149F31-9DFB-4DB5-A5DE-910974E0C325Q45749294-A2725332-B186-4C10-9629-7CBCF421C0B2Q45855694-0F5D80FC-E49A-461B-BB8F-32168288E24EQ47589446-E6D2DBED-D5E1-4111-9B47-EC916A00F5D9
P2860
Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Receptor-mediated gene transfe ...... e CD3 T cell receptor complex.
@en
Receptor-mediated gene transfe ...... e CD3 T cell receptor complex.
@nl
type
label
Receptor-mediated gene transfe ...... e CD3 T cell receptor complex.
@en
Receptor-mediated gene transfe ...... e CD3 T cell receptor complex.
@nl
prefLabel
Receptor-mediated gene transfe ...... e CD3 T cell receptor complex.
@en
Receptor-mediated gene transfe ...... e CD3 T cell receptor complex.
@nl
P2093
P356
P1433
P1476
Receptor-mediated gene transfe ...... he CD3 T cell receptor complex
@en
P2093
Birnstiel ML
Kirlappos H
Mechtler K
Schaffner G
P304
P356
10.1089/HUM.1995.6.6-753
P577
1995-06-01T00:00:00Z